Joined J-STAR in 2022. He is engaged in investments and value-up activities for Tokuyama Shokai Group (Demolition work), GENEX (wholesale of generic drugs). Before Joining J-STAR, he worked for KPMG Healthcare Japan for approximately 6 years. The projects he has advised on include M&A advisory, strategy development, corporate restructuring, etc. mainly in healthcare sectors. His clients include global/local investment banks, private equity funds, Japanese trading houses, global/local financial institutions, leading private hospitals, senior care service providers, and other companies in related sectors. Before that, he worked for Central Japan Railway Company and engaged in operating bullet trains, etc. He graduated from Master of Science in Engineering, Kyoto University